Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward

The COVID-19 pandemic mandates the development of a safe and effective Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccine. This review analyzes the complexities, challenges, and other vital issues associated with the development of the SARS-CoV-2 vaccine. A brief review of the immu...

Full description

Bibliographic Details
Main Authors: Vipin M. Vashishtha, Puneet Kumar
Format: Article
Language:English
Published: Taylor & Francis Group 2021-06-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
sars-cov-2 vaccines
vaccine development
immune responses
neutralizing antibodies
antibody-dependent enhancement
Online Access:http://dx.doi.org/10.1080/21645515.2020.1845524

Internet

http://dx.doi.org/10.1080/21645515.2020.1845524

Similar Items